Doctors quizzed on inflammation blood test for heart and kidney patients
NCT ID NCT07160829
First seen Oct 31, 2025 · Last updated May 14, 2026 · Updated 23 times
Summary
This completed study surveyed 608 heart and kidney specialists to understand their awareness and use of a blood test called hsCRP, which measures inflammation. The goal was to learn what doctors think about inflammation's role in managing atherosclerotic cardiovascular disease, chronic kidney disease, and heart failure. No treatments were given; it was purely a knowledge-gathering survey.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEART FAILURE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Novo Nordisk Investigational Site
Sydney, 2060, Australia
-
Novo Nordisk Investigational Site
Bangalore, Karnataka, India
-
Novo Nordisk Investigational Site
Seoul, South Korea
-
Novo Nordisk Investigational Site
Bangkok, Thailand
Conditions
Explore the condition pages connected to this study.